FINE NEEDLE ASPIRATION CYTOLOGICAL STUDIES OF THYROID LESIONS AND THEIR CLASSIFICATION BY BETHESDA SYSTEM OF REPORTING.
Main Article Content
Keywords
Thyroid lesions, Benign, Malignant, FNAC, BSRTC
Abstract
Background: Thyroid lesions are commonly encountered in clinical practice, and the differentiation between benign and malignant nodules is crucial for appropriate management. Fine Needle Aspiration Cytology (FNAC) is a widely used diagnostic tool to evaluate thyroid lesions due to its minimally invasive nature, accuracy, and cost-effectiveness. The Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) provides a standardized approach to classify thyroid FNAC results, enhancing communication between pathologists and clinicians. The aim of this study was to evaluate the utility of FNAC in the diagnosis of thyroid lesions and to classify them according to the Bethesda system, assessing its impact on patient management.
Methodology: This retrospective study was conducted over a period of one year and included 150 patients who underwent FNAC for thyroid lesions at a tertiary care center. FNAC specimens were collected from patients with clinically suspicious thyroid nodules, and cytological findings were categorized based on the Bethesda System, which includes six diagnostic categories: non-diagnostic, benign, atypia of undetermined significance (AUS), follicular neoplasm, suspicious for malignancy, and malignant.
Results: In the present study, 199 cases of thyroid FNAC were received during the 2 years of study. These were categorized according to the Bethesda system of reporting thyroid cytology in to 6 categories. The distribution of FNAC findings was as follows; 70.8% benign, 4.5% AUS, 13% follicular neoplasm, 3.01% suspicious for malignancy, and 2.01% malignant. The Bethesda system allowed for better risk stratification and management decisions.
Conclusion: FNAC, when coupled with the Bethesda System for Reporting Thyroid Cytopathology, is an effective and reliable tool for evaluating thyroid lesions. The Bethesda classification helps stratify patients based on the risk of malignancy and guides clinical decision-making, reducing unnecessary surgeries while ensuring prompt management for patients with malignant nodules.
References
2. Puri R, Aggawal R, Chadda P, Sharma S, Mishra J. Fine needle aspiration cytology of thyroid lesions and classification as per the Bethesda system. Indian J Pathol Oncol. 2018;5(2):189-94.
3. Bhartiya R, Mallik M, Kumari N, Prasad BN. Evaluation of thyroid lesions by fine-needle aspiration cytology based on Bethesda system for reporting thyroid cytopathology classification among the population of South Bihar. Indian J Med Paediatr Oncol. 2016;37:265-70.
4. Nandedkar SS, Dixit M, Malukani K, Varma AV, Gambhir S. Evaluation of thyroid lesions by fine-needle aspiration cytology according to Bethesda system and its histopathological correlation. Int J Appl Basic Med Res. 2018;8(2):76-82.
5. Menon AS. Rising prevalence of thyroid disorders in India - The time to act is now. Thyroid Res Pract. 2020;17(3):99-100.
6. Menon V, Sundaram KR, Unnikrishnan AG, Jayakumar RV, Nair V, Kumar H. High prevalence of undetected thyroid disorders in an iodine sufficient adult south Indian population. J Indian Med Assoc. 2009;107:72-7.
7. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295:2164-7.
8. Ray S, Manna AK, Sen S, Pathak S, Chakraborty D, Bhattacharya P. Morphometry of thyroid lesion with cytological and histological correlation. J Cytol. 2006;23:113-8.
9. Jamaiyar A, Yogesh K. How accurate is fine-needle aspiration cytology (FNAC) for thyroid lesion: A correlation of FNAC with histopathology. J Family Med Prim Care. 2023 Jan;12(1):15-20.
10. Sinna EA, Ezzat N. Diagnostic accuracy of fine needle aspiration cytology in thyroid lesions. J Egypt Natl Cancer Inst. 2012;24(2):63-70.
11. Al Maqbali T, Tedla M, Weickert MO, Mehanna H. Malignancy risk analysis in patients with inadequate fine needle aspiration cytology (FNAC) of the thyroid. PLoS One. 2012;7(11):e49078.
12. Eng OS, Potdevin L, Davidov T, Lu SE, Chen C, Trooskin SZ. Does nodule size predict compressive symptoms in patients with thyroid nodules? Gland Surg. 2014 Nov;3(4):232-6.
13. Banks CA, Ayers CM, Hornig JD, et al. Thyroid disease and compressive symptoms. Laryngoscope. 2012;122:13-6.
14. Sengupta A, Pal R, Kar S, Zaman FA, Basu M, Pal S. Clinico-pathological correlates of incidentally revealed thyroid swelling in Bihar, India. J Pharm Bioallied Sci. 2012 Jan;4(1):51-5.
15. Patel NR, Patel AV, Patel VV, Vadher PR, Kakadia MB. Ultrasonographic and fine needle aspiration cytology correlation of thyroid gland lesions: A study of 100 cases. Int J Otorhinolaryngol Head Neck Surg. 2019;5:319-25.
16. Kumari T, Kumar A, Sharma SK. A hospital based observational assessment of thyroid swelling and its management: Clinicopathological study. Int J Curr Pharm Rev Res. 2023;15(12):50-54.
17. Daimary M, Choubey RN, Nath J. Clinicopathological spectrum of thyroid swelling: A single institutional prospective study from Northeast India. Asian Pac J Cancer Care. 2023;8(2):337-41.
18. Mehar R, Meshram S, Mittal M. Comparative reporting of thyroid cytology using Bethesda system with that of conventional system. J Med Sci Clin Res. 2019;7(3).
19. Munavarah S, Bhosale A, Jeybalan N. Fine needle aspiration cytopathology of thyroid lesions reporting as per guidelines of recent Bethesda system at a tertiary care teaching medical college & hospital. Int J Sci Res. 2019;8(2):29-31.
20. Shrivastava P, Meenai F. Application of Bethesda reporting system of thyroid cytology and its clinical significance. Saudi J Pathol Microbiol. 2020 May;5(5):263-70.
21. Choden S, Wangmo C, Mahajan S. Application of Bethesda system for reporting thyroid cytopathology for classification of thyroid nodules: A clinical & cytopathological characteristics in Bhutanese population. J Diagn Cytopathol. 2021;1-9.